<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:Helvetica;
panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
span.xapple-converted-space
{mso-style-name:x_apple-converted-space;}
span.EmailStyle21
{mso-style-type:personal-reply;
font-family:"Calibri",sans-serif;
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="blue" vlink="purple" style="word-wrap:break-word">
<div class="WordSection1">
<p class="MsoNormal"><b>Please disseminate to researchers in your department.<o:p></o:p></b></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">***************************<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<div>
<div>
<p class="MsoNormal">Dear Colleagues, <o:p></o:p></p>
<div>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
<div>
<p class="MsoNormal">Attached for distribution is an announcement from the Center for Medicinal Cannabis Research at UCSD which includes a request for applications (RFA). <br>
<span style="color:#5856D6"><br>
</span>The Center for Medicinal Cannabis Research (CMCR) is seeking to fund primary and pilot cannabis-related studies that further enhance the understanding of the efficacy and adverse effects of cannabis and cannabinoids as pharmacological agents for the
treatment of medical and psychiatric disorders, and their potential public health impacts. Primary project awards will be up to $825,000 in total costs ($275,000 per year) for up to three years. Pilot awards will be up to $300,000 total costs for two years
($150,000 per year). Priority will be given to proposals addressing issues identified under Funding Priorities.<br>
<span style="color:red"><br>
<b><i><u>Key Dates</u></i></b></span><br>
<b><span style="color:red">Letter of Intent Due</span></b><br>
<span style="color:red">April 7, 2021 2 pm PDT</span><br>
<span style="color:red"><br>
<b>Application Due</b></span><br>
<span style="color:red">June 2, 2021 2 pm PDT</span><br>
<span style="color:red"><br>
<b>Review</b></span><br>
<span style="color:red">July - August 2021</span><br>
<b><span style="color:red"><br>
Earliest Start Date</span></b><br>
<span style="color:red">October 1, 2021</span><br>
<span style="color:#5856D6"><br>
</span><b><i>Funding Priorities</i></b><br>
Funding priorities include studies that 1) provide proof-of-principle findings that inform future, more comprehensive studies, 2) address scientific gaps identified by authoritative reviews (e.g., ‘The Health Effects of Cannabis and Cannabinoids’, National
Academy of Sciences, Engineering, and Medicine; 2017), or 3) represent promising new directions for research. <br>
<span style="color:#5856D6"><br>
</span>With regard to cannabis therapeutics there is no pre-determined list or priority ranking of disorders eligible for funding. Instead, applicants are encouraged to consider the findings of ‘The Health Effects of Cannabis and Cannabinoids’, National Academy
of Sciences, Engineering, and Medicine; 2017, or other authoritative reviews as a starting point for areas of study. <br>
<span style="color:#5856D6"><br>
</span>Although the CMCR focus is on the potential of cannabis for therapeutics of medical and psychiatric disorders, applications may address adverse effects of cannabis (e.g., effects on cognition; mental health; driving and public safety; drug-drug interactions),
and effects on certain populations (eg, elderly, women’s health). Applications addressing the role of cannabinoids in COVID will also be considered. <br>
<span style="color:#5856D6"><br>
</span>Applicants are encouraged to review CMCR’s portfolio of recently-funded grants (<a href="https://urldefense.com/v3/__https:/www.cmcr.ucsd.edu/index.php/news-2/announcements/287-cmcr-grants-programoverview__;!!LLK065n_VXAQ!3Es0B2FpcX-9NdK-0SyPmpOO6xIcoPZP5duRtB9VJZve5HuMwqSCCIVh7F0dIZfnT_o$">https://www.cmcr.ucsd.edu/index.php/news-2/announcements/287-cmcr-grants-programoverview</a>).
While the fact that certain areas are already being supported does not constitute an exclusion, CMCR is looking to studies that open new directions. <br>
<span style="color:#5856D6"><br>
</span>The CMCR will also consider basic science and animal studies with clear translational implications for human health and disease. Studies of assays/methods for detection of cannabinoids, endocannabinoids, related substances are likewise eligible. <br>
<span style="color:#5856D6"><br>
</span>Proof of principle clinical studies are encouraged, as are proposals that leverage other funding (e.g., from other grant sources, foundations, in-kind contributions of equipment or services, etc.). Applicants are encouraged to consider psychoactive cannabinoids
(e.g., delta-9- tetrahydrocannabinol, THC) as well as well as “minor” cannabinoids, and related compounds (e.g. terpenoids), and drugs directly affecting function and pathways of the endocannabinoid system as potential test agents.<br>
<span style="color:#5856D6"><br>
</span><b><i>Application Instructions</i></b><br>
Applications will be submitted via proposalCENTRAL (<a href="https://urldefense.com/v3/__https:/proposalcentral.com/__;!!Mih3wA!VTfr9O3_J01s15I19C9L7INRInbCwvyqZ0vDlYoK2YgwdZ-Zz_RJK8Y4yaq_8QaENw$"><span style="color:purple">https://proposalcentral.com/</span></a>).
Search “CMCR Grants Program” to locate the application. Please review the attached RFA for instructions. Instructions and document templates can also be found on proposalCENTRAL. <o:p></o:p></p>
</div>
<div>
<p class="MsoNormal"><span style="color:#5856D6"><br>
</span><b>Please see the attached announcement for more details. If you have any questions, or need assistance with your proposal, please contact </b><a href="mailto:CMCRgrants@ucsd.edu"><span style="color:purple">CMCRgrants@ucsd.edu</span></a>.<br>
<span style="color:#5856D6"><br>
</span><b>Center for Medicinal Cannabis Research (CMCR)</b><br>
University of California, San Diego<br>
<a href="https://urldefense.com/v3/__http:/cmcr.ucsd.edu/__;!!LLK065n_VXAQ!3Es0B2FpcX-9NdK-0SyPmpOO6xIcoPZP5duRtB9VJZve5HuMwqSCCIVh7F0dcUYO9mI$"><span style="color:purple">cmcr.ucsd.edu</span></a> <o:p></o:p></p>
<div>
<div>
<div>
<div>
<p class="MsoNormal"><span style="color:purple"><a href="mailto:CMCRgrants@ucsd.edu">CMCRgrants@ucsd.edu</a></span><o:p></o:p></p>
</div>
</div>
</div>
</div>
<div>
<div>
<div>
<div>
<div>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
<div>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
<div>
<p class="MsoNormal">.....................................................................................<o:p></o:p></p>
</div>
</div>
</div>
</div>
</div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<p class="MsoNormal"><b><span style="color:black">Carla Ingle<span class="xapple-converted-space"> </span></span></b><span style="color:black">|<b> </b>Project Coordinator<br>
<a href="https://urldefense.com/v3/__https:/www.mypronouns.org__;!!Mih3wA!V3W2MgW5JWZuHqSAWwfhVVludORr1SEJ512IR6Dt6In4udgEC931jYKjsIvWUasyfkE7UFD0VHb43gF2mQ$">she/her/hers</a><o:p></o:p></span></p>
</div>
<div>
<p class="MsoNormal"><br>
<b><span style="color:black">Center for Medicinal Cannabis </span>Research (CMCR)</b><br>
UC San Diego Health | 619-543-4749 | <a href="mailto:cingle@health.ucsd.edu"><span style="color:black;text-decoration:none">cingle@health.ucsd.edu</span></a><o:p></o:p></p>
</div>
<div>
<div>
<p class="MsoNormal"><span style="font-size:9.0pt;font-family:"Helvetica",sans-serif;color:black"><o:p> </o:p></span></p>
</div>
<div>
<p class="MsoNormal"><span style="font-size:9.0pt;font-family:"Helvetica",sans-serif;color:black"><o:p> </o:p></span></p>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
<div>
<div>
<div>
<div>
<p class="MsoNormal" style="margin-bottom:12.0pt"><o:p> </o:p></p>
</div>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
</div>
</div>
</div>
</body>
</html>